Related Experiment Video
Updated: Aug 15, 2025

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
A conservative treatment for eosinophilic cystitis.
Franco Alchiede Simonato1, Nicola Pavan2, Mirko Pinelli2
1University of Genoa Urology Clinic Genoa Italy.
Eosinophilic cystitis, a rare condition, presents diagnostic challenges. This case highlights a conservative management approach, including novel hyperbaric therapy for severe hematuria.
Area of Science:
- Urology
- Pathology
- Internal Medicine
Background:
- Eosinophilic cystitis is a rare bladder condition with diverse etiologies, often mimicking other diseases.
- Differential diagnosis is challenging due to non-specific symptoms and varied causes including hypereosinophilic syndrome, infections, and drug reactions.
Observation:
- A middle-aged male presented with eosinophilic cystitis, characterized by persistent hematuria and symptoms suggestive of hypereosinophilic crisis.
- The patient's presentation underscored the diagnostic complexity of eosinophilic cystitis.
Findings:
- Conservative management, including corticosteroids and antihistamines, is the preferred approach over radical cystectomy.
- Hyperbaric oxygen therapy emerged as a potential innovative treatment for severe, relapsing gross hematuria in this case.
Implications:
- This case suggests a conservative treatment strategy for eosinophilic cystitis, emphasizing medical management.
- Further research into hyperbaric therapy for refractory hematuria in eosinophilic cystitis is warranted.
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Urologic Endoscopic Procedure: Cystoscopic Examination
Drugs for Treatment of Constipation-Predominant IBS
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Acute Pyelonephritis II: Diagnostic Studies and Management
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

